Michelson Diagnostics issues preliminary specs for clinical handheld OCT probe

JANUARY 26, 2009--Michelson Diagnostics (London, UK) has issued a preliminary specification for its clinical optical coherence tomography (OCT) probe and processing system, which the company demonstrated this past weekend at the SPIE's BiOS exhibition. The system, named Vivosight, will be available with two probe versions--one with X-Y scanning to enable 3D mapping of flat tissue such as skin, and the other with a rigid endoscope for internal applications. Michelson plans to launch the new Vivosight OCT system commercially in late spring 2009.